Peking University School and Stance3D Establish Joint Lab in Chongqing to Advance Ultra-High-Precision Dental Surface Enhancement Technology

On July 30, the Joint Laboratory for Ultra-High Precision Tooth Surface Reinforcement Technology, established by Peking University School and Hospital of Stomatology and BMF Precision Tech Inc. (hereinafter referred to as “BMF Precision Tech”), was unveiled in Liangjiang New Area. The Series D financing signing ceremony of BMF Precision Tech and the First Academic Symposium on the Development of the Precision Manufacturing Industry were held concurrently.

Signing Ceremony Venue

The conference commenced with the signing ceremony for BMF Precision Tech’s Series D financing round. In the presence of 12 academicians and experts, including Hou Li’an, Ge Changchun, Zhu Meifang, Liu Wenqing, Pan Fusheng, Li Jinghong, Yu Shuhong, Zhang Ping, Tan Jianrong, Yu Aibing, Zhang Qin, and Zhang Jing’an, the National Manufacturing Transformation and Upgrading Fund, Guotai Junan Innovation Investment Fund of Funds, Zhangjiang Sci-Tech Innovation Investment, Chongqing Jianxin Heying, Hongying Capital, Guangzhou Yunfan Technology, and BMF Precision Tech signed the financing agreement on site. The Series D financing totaled RMB 170 million, marking another round of funding completed within one year following BMF Precision Tech’s RMB 300 million Series C financing in 2022.

Dr. He Xiaoning, Chairman of BMF Precision Tech, stated that the miniaturization, precision enhancement, and increasing complexity of devices represent major trends in industrial development. As a pioneer and global leader in ultra-high-precision micro-nano 3D printing technology, BMF Precision Tech will leverage its long-accumulated core technologies, uphold independent innovation, continuously enrich its product portfolio, and strive to provide customers worldwide with disruptive precision manufacturing solutions.

This round of financing will be used to deepen the research and industrialization of end-use applications such as dental veneers and organ-on-a-chip, continuously expand the scope of end-use applications, and consolidate BMF Precision Tech’s dominant position in the global ultra-high-precision 3D printing sector.Going forward, BMF Precision Tech will continue to deepen its presence in end-use sectors such as precision medicine and high-end manufacturing, continuously enhance its innovative R&D capabilities, and further advance and expand its portfolio of end products.

Unveiling Ceremony of the Joint Laboratory

During the conference, Professor Sun Yuchun, Director of the Joint Laboratory for Ultra-High Precision Tooth Surface Reinforcement Technology and from the Digital Research Center of Peking University School and Hospital of Stomatology, and Dr. Xia Chunguang, Chief Technology Officer of BMF Precision Tech, jointly unveiled the plaque for the joint laboratory.

Remarks by Professor Sun Yuchun, Digital Research Center, Peking University School and Hospital of Stomatology

Professor Sun Yuchun stated, “The ultra-thin, high-strength 3D-printed zirconia veneer technology can”Ceramic VeneersThickness reduced from 400 μm to a minimum of 40 μm, it can rapidly and painlessly strengthen and protect the tooth surface, shielding it from cold and acidic stimuli as well as abrasion, while making teeth whiter and more aligned. More importantly, compared with traditional ceramic veneer techniques, this process reduces tooth reduction by 90% or even eliminates the need for drilling altogether.

"In the future, the Joint Laboratory of Peking University School of Stomatology and Chongqing BMF Precision Tech for Ultra-High-Precision Surface Strengthening Technology will further increase its investment in scientific research. While ensuring excellent strength and transparency, it strives to reduce the minimum processing thickness of ultra-thin, high-strength zirconia veneers to 10 micrometers, thereby further expanding the technology’s international leading advantage and clinical application efficacy, and making greater contributions to the non-invasive prevention and treatment of dental diseases."

Speech by Dr. Gong Xiaofeng of the Fudan University Scientific Team

In the field of bioreactors, Shanghai Bozhen Biotech and BMF Precision Tech have established a research and development center in San Diego, USA, where they have designed and developed innovative cell culture chips. These chips provide a precise, reliable, and stable research platform for tumor models, organ models, drug screening, regenerative medicine, and precision medicine. The bioreactors produced using high-precision 3D printing technology featureCapillary-like structures with a wall thickness of 100 μm and infusion pores smaller than 5 μm, enabling internal and external nutrient supply through capillary-like perfusion, thereby addressing the issues of oxygen and nutrient deficiency.

Dr. Gong Xiaofeng of the Fudan University scientific team introduced that organ-on-a-chip systems, composed of bioreactors and organoids with high similarity to human organs, are currently under development. These efforts aim to achieve functional volumetric maturation and standardized culture conditions, driving breakthroughs across temporal and spatial dimensions and bridging the “last mile” of the organoid technology revolution.

Speech by Hu Ligang, Founder of Hangzhou Ruisinade Precision Technology Co., Ltd.

In the field of consumables for inductively coupled plasma mass spectrometry (ICP-MS), we collaborate with Hangzhou Ruisinade Precision Technology Co., Ltd. to jointly develop key components and high-value consumables for mass spectrometers; currently, there are no domestic manufacturers with independent intellectual property rights in this area.

Hu Ligang, founder of Hangzhou Ruisinade Precision Technology Co., Ltd. and researcher at the Research Center for Eco-Environmental Sciences of the Chinese Academy of Sciences, introduced that this technology provides a solution for the “domestic substitution” of high-value consumables and core components of mass spectrometry detectors. BMF’s ultra-high-precision 3D printing technology enables precise control over internal structures while significantly reducing costs, with the final market price being only one-tenth that of the original products. This innovation transforms ordinary consumables into single-use ones, eliminating safety hazards associated with repeated tube clearing and contact with biological samples.

At the conference, 12 academicians and experts affirmed the R&D collaboration on applying BMF Precision Tech’s 3D printing systems to dental veneers, organ-on-a-chip devices, mass spectrometers, and other applications.and discussed the future development direction, industrial needs, and application scenarios of the precision manufacturing industry.

BMF Precision Tech, established in 2016, is currently the world’s only provider of industrialized 3D printing systems capable of achieving a maximum precision of 2 μm. Its projection micro-stereolithography (PμSL) additive manufacturing technology offers exceptional forming precision and tolerance control. By integrating various high-performance materials with related post-processing techniques, BMF has developed an integrated technology encompassing equipment, materials, and processes, thereby providing a novel solution for precision manufacturing.

As of June 2023, BMF Precision Tech has established collaborations with nearly 2,000 research institutions and industrial enterprises across 35 countries worldwide, among whichwithPartnerships have been established with all of the top 10 global medical device companies, including Johnson & Johnson and GE Healthcare.

The National Manufacturing Transformation and Upgrading Fund was established in November 2019 with a registered capital of RMB 147.2 billion. Its shareholders include ministries such as the Ministry of Finance, central enterprises like CDB Capital and China Tobacco, and local state-owned asset platforms including Yangtze River Industry Investment and Yizhuang State-owned Capital Investment. The fund primarily makes strategic investments in growth-stage and mature companies across sectors such as new materials, next-generation information technology, power equipment, high-end CNC machine tools and basic manufacturing equipment, industrial robots, core components and electronic devices, key instruments and meters, aerospace, and the new energy vehicle industry chain, thereby positioning itself in leading enterprises within these manufacturing segments.

Guotai Junan Innovation Investment Co., Ltd. is a wholly-owned private equity investment management subsidiary under Guotai Junan Securities. It is responsible for managing various alternative assets, including private equity, special opportunities, and new infrastructure, with assets under management exceeding RMB 60 billion. Adhering to technology-driven innovation as its guiding principle, the company is committed to supporting the implementation of national strategies and the growth of the real economy. The company focuses on four key sectors: emerging technologies, biopharmaceuticals, green development, and consumer livelihoods. It has established a core business layout centered on “fund-of-funds + industrial funds” and developed alternative investment lines in urban renewal, new infrastructure, and special opportunities.